Search Results for keywords:"Executive Order 14195"

The President issued Executive Order 14228, amending a previous order (Executive Order 14195) to increase tariffs on products from China from 10% to 20%. This decision was made because the Chinese government has not taken adequate steps to address the inflow of synthetic opioids, like fentanyl, which poses a threat to U.S. national security and economy. The order underscores that it is consistent with applicable law and does not confer any new rights enforceable at law.

The Department of Homeland Security has updated the rules regarding additional duties on products from China, including Hong Kong, due to changes in an Executive Order. These changes raise the tariffs from 10% to 20% on certain items, effective March 4, 2025. The order is part of a response to what the U.S. views as China's inadequate control over synthetic opioid supply chains. Some exceptions apply, such as items qualifying for de minimis exemptions, but these could change if the government determines that enough systems are in place to manage tariff revenues.

The Executive Order 14195, issued by President Donald J. Trump, addresses the impact of synthetic opioids, mainly from China, on the United States. It highlights that these opioids cause significant harm, including deaths and societal issues, and criticizes China's role in the drug trade. To counter this, the order expands a national emergency declaration, mandating an additional 10% import duty on Chinese goods, subject to certain conditions. This action aims to pressure China into taking more stringent measures against illegal opioid distribution.